-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DITY2BzgMmCYMkwyAjjlU9m5/vwM0tNNrxoithfpzAUpFmJGofOzWZFRi2LmONrc xhx4m6rcX00fsL1Kxfeo7w== 0000886163-11-000014.txt : 20110218 0000886163-11-000014.hdr.sgml : 20110218 20110218194539 ACCESSION NUMBER: 0000886163-11-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110217 FILED AS OF DATE: 20110218 DATE AS OF CHANGE: 20110218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11085 NORTH TORREY PINES ROAD STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 11085 NORTH TORREY PINES ROAD STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIGGINS JOHN L CENTRAL INDEX KEY: 0001208906 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 11626115 MAIL ADDRESS: STREET 1: 11085 NORTH TORREY PINES ROAD, SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2011-02-17 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001208906 HIGGINS JOHN L 11085 NORTH TORREY PINES ROAD, SUITE 300 LA JOLLA CA 92037 1 1 0 0 President & CEO Common Stock 2011-02-17 4 A 0 15000 0 A 88494 D Incentive Stock Option (right to buy) 10.05 2011-02-17 4 A 0 20343 10.05 A 2021-02-17 Common Stock 20343 20343 D Non-Qualified Stock Option (right to buy) 10.05 2011-02-17 4 A 0 94657 10.05 A 2021-02-17 Common Stock 94657 94657 D Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Optioned Shares per month thereafter. By: John P. Sharp For: John L. Higgins 2011-02-18 -----END PRIVACY-ENHANCED MESSAGE-----